Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 365-374

  Murata, Kazuko ^a,b   Ishii, Naoto ^a   Takano, Hiroshi ^d   Miura, Shigeto ^a,b   Ndhlovu, Lishomwa C ^a   Nose, Masato ^c   Noda, Tetsuo ^b,d   Sugamura, Kazuo ^a,b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CANCER INSTITUTE   (Japan)

Author keywords

Antigen presenting cell function; Cytokine; OX40 ligand; OX40 ligand mutant mice; T cell priming

Indexed keywords

ALLOANTIGEN; CD40 ANTIGEN; GLYCOPROTEIN; HEMOCYANIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; CELL FUNCTION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOPHENOTYPING; ISOANTIGENS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTORS;

EID: 0034677176     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.365     Document Type: Article

References (43)

1. I detected only on CD4 positive T blasts. Mol. Immunol. 24:1281-1290.
2. Mallett, S., S. Fossum, and A.N. Barclay. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO (Eur. Mol. Biol. Organ.) J. 9:1063-1068.
3. Al-Shamkhani, A., M.L. Birkeland, M. Puklavec, M.H. Brown, W. James, and A.N. Barclay. 1996. OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand. Eur. J. Immunol. 26:1695-1699.
4. Calderhead, D.M., J.E. Buhlmann, A.J.M. Van der Eetwegh, E. Claasen, R.J. Noelle, and H.P. Fell. 1993. Cloning of mouse Ox40: a T cell activation marker that may mediate T-B interactions. J. Immunol. 151:5261-5271.
5. Baum, P.R., R.B. Gayle, F. Ramsdell, S. Srinivasan, R.A. Sorensen, M.L. Watson, M.F. Seldin, E. Baker, G.R. Sutherland, and K.N. Clifford. 1994. Molecular characterization of murine and human OX-40/OX-40 ligand systems: identification of a human OX-40 ligand as the HTLV-1-regulated protein gp34. EMBO (Eur. Mol. Biol. Organ.) J. 13:3992-4001.
6. Higashimura, N., N. Takasawa, Y. Tanaka, M. Nakamura, and K. Sugamura. 1996. Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I. Jpn. J. Cancer Res. 87: 227-231.
7. Weinberg, A.D., J.J. Wallin, R.E. Jones, T.J. Sullivan, D.N. Bourdette, A.A. Vandenbark, and H. Offner. 1994. Target organ-specific up-regulation of the MRC OX-40 marker and selective production of Th1 lymphokine mRNA by encephalitogenic T helper cells isolated from the spinal cord of rats with experimental autoimmune encephalomyelitis. J. Immunol. 152:4712-4721.
8. Weinberg, A.D., D.N. Bourdette, T.J. Sullivan, M. Lemon, J.J. Wallin, R. Maziarz, M. Davey, F. Palida, W. Godfrey, E. Engleman, et al. 1996. Selective depletion of myelin-reactive T cells with the anti-OX-40 antibody ameliorates autoimmune encephalomyelitis. Nat. Med. 2:183-189.
9. Matsumura, Y., A. Imura, T. Hori, T. Uchiyama, and S. Imamura. 1997. Localization of OX40/gp34 in inflammatory skin diseases: a clue to elucidate the interaction between activated T cells and endothelial cells in infiltration. Arch. Dermatol. Res. 289:653-656.
10. Vetto, J.T., S. Lumm, A. Morrism, M. Sicotte, J. Davis, M. Lemon, and A.D. Weinberg. 1997. Presence of the T-cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancers. Am. J. Surg. 174:258-265.
11. Tittle, T.V., A.D. Weinberg, C.N. Steinkeler, and R.T. Maziarz. 1997. Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood. 89:4652-4658.
12. Stüber, E., A. Von Freier, D. Marinescu, and U.R. Folsch. 1998. Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease. Gastroenterology. 115:1205-1215.
13. Higgins, L.M., S.A. McDonald, N. Whittle, N. Crockett, J.G. Shields, and T.T. MacDonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162:486-493.
14. Weinberg, A.D., K.W. Wegmann, C. Funatake, and R.H. Whitham. 1999. Blocking OX-41/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162:1818-1826.
15. Miura, S., K. Ohtani, N. Numata, M. Niki, K. Ohbo, Y. Ina, T. Gojobori, Y. Tanaka, H. Tozawa, M. Nakamura, and K. Sugamura. 1991. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol. Cell. Biol. 11:1313-1325.
16. Stüber, E., M. Neurath, D. Calderhead, H.P. Fell, and W. Strober. 1995. Crosslinking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 2:507-521.
17. Stüber, E., and W. Strober. 1996. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J. Exp. Med. 183:979-989.
18. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M. Maeda, S. Imamura, and T. Uchiyama. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183:2185-2195.
19. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewiski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159: 3838-3848.
20. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of Cd4 T cells in B follicles. Eur. J. Immunol. 29: 1610-1616.
21. Janeway, C.A., Jr., and K. Bottomly. 1994. Signals and signs for lymphocyte responses. Cell. 76:275-285.
22. Lenschow, D.J., T.L. Walunas, and J.A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
23. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180:757-762.
24. Gramaglia, I., A.D. Weinberg, M. Lemon, and M. Croft. 1998. OX-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J. Immunol. 161: 6510-6517.
25. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita, and K. Okumura. 1999. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J. Immunol. 162:7058-7066.
26. Niki, M., H. Okada, H. Takano, J. Kuno, K. Tani, H. Hibino, S. Asano, Y. Ito, M. Satake, and T. Noda. 1997. Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA. 94:5697-5702.
27. Nakai, S., H. Kawano, T. Yudate, M. Nishi, J. Kuno, A. Nagata, K. Jishage, H. Hamada, H. Fujii, K. Kawamura, et al. 1995. The POU domain transcription factor Brn-2 is required for the determination of specific neuronal lineages in the hypothalamus of the mouse. Genes Dev. 9:3109-3121.
28. Takeshita, T., Y. Goto, K. Tada, K. Nagata, H. Asao, and K. Sugamura. 1989. Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor. J. Exp. Med. 169:1323-1332.
29. Vremec, D., and K. Shortman. 1997. Dendritic cell subtypes in mouse lymphoid organs. J. Immunol. 159:565-573.
30. Grewal, I.S., X. Jianchao, and R.A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:617-620.
31. Nagata, K., K. Tanaka, K. Ogawa, K. Kemmotsu, T. Imai, O. Yoshie, H. Abe, K. Tada, M. Nakamura, K. Sugamura, and S. Takano. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J. Immunol. 162:1278-1286.
32. Yasuda, K., T. Nemoto, Y. Obashi, S. Satomi, K. Murata, N. Ishii, T. Takeshita, and K. Sugamura. 1998. Prolongation of allograft survival by administration of mAb specific for the three subunits of IL-2 receptor. Int. Immunol. 10:561-567.
33. Tanaka, Y., T. Inoi, H. Tozawa, N. Yamamoto, and Y. Hinuma. 1985. A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I). Int. J. Cancer. 36:549-555.
34. - T cells into high IL-4-producing effectors. Blood. 92:3338-3345.
35. Flynn, S., K.M. Toellner, C. Raykundalia, M. Goodall, and P. Lane. 1998. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 188:297-304.
36. Weinberg, A.D., A.T. Vella, and M. Croft. 1998. OX-40: life beyond the effector T cell stage. Semin. Immunol. 10:471-180.
37. Vella, A.T., J.E. McCormack, P.S. Linsley, J.W. Kappler, and P. Marrack. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 2:261-270.
38. Foy, T.M., A. Aruffo, J. Bajorath, J.H. Buhlmann, and R.J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591-617.
39. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
40. Van Gool, S.W., P. Vandenberghe, M. de Boer, and J.L. Ceuppens. 1996. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 153:47-83.
41. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1994. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269:1424-1427.
42. Ohtani, K., A. Tsujimoto, T. Tsukahara, N. Numata, S. Miura, K. Sugamura, and M. Nakamura. 1998. Molecular mechanisms of promoter regulation of the gp34 gene that is transactivated by an oncoprotein tax ot the human T cell leukemia virus type I. J. Biol. Chem. 273:14119-14129.
43. Essen, D., H. Kikutani, and D. Gray. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378:620-623.